Author's posts
Culture disconnect within an organization: 5 things to know
About 2 in 10 employees feel strongly connected to their workplace culture, according to a recent Gallup survey covered in an Oct. 18 report from the organization.
AdventHealth University offers certificates for high schoolers: 5 things to know
Orlando, Fla.-based AdventHealth University has launched a program for high school students to earn certifications in seven healthcare roles.
NYU Langone's 'superpower' for pursuing innovation
NYU Langone Health wasn’t always a pioneer in transplantation.
Hutchinson Health president to retire, successor named
Nathan Pulscher has been named the next president of Hutchinson (Minn.) Health, part of Bloomington, Minn.-based HealthPartners.
How Ascension Florida's CEO is expanding care for 'most vulnerable patients'
Ascension Florida, a nonprofit Catholic system, is ramping up efforts to expand access to high-quality, complex care for North Florida’s most vulnerable populations, with new facilities, advanced technologies, and a focus on keeping patients close to h…
PE firm to invest in CorroHealth
Private equity firm Patient Square Capital has signed a definitive agreement for a strategic investment in revenue cycle management company CorroHealth.
How a new Bon Secours hospital is preparing for a growing, aging population
The population of Suffolk, Va., has approximately doubled since 1990, and that growth is expected to continue, said Andy Spicknall, president of the new Bon Secours Harbour View Medical Center, which is expected to open in the spring.
Number of drug shortages eases from all-time high: 5 notes
In April, the American Society of Health-System Pharmacists reported 323 ongoing drug shortages — the highest number since the organization began tracking them in 2001. The number has since fallen to 277.
Prospect, Yale New Haven $435M hospital deal issues drag on
Connecticut has told Los Angeles-based Prospect Medical Holdings that it wants monitors on board at its three state hospitals amid ongoing disputes with Yale New Haven (Conn.) Health over a $435 million stalled deal for the facilities.
Alzheimer's drug trials raise ethical concerns over risk disclosure
A recent investigation by The New York Times revealed that two pharmaceutical companies, Eisai and Eli Lilly, withheld critical genetic risk information from volunteers during clinical trials for Alzheimer’s drugs, Leqembi and Kisunla.
